SEC Form 4 · accession 0001193125-26-279833
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean Mackay
Officer — SVP & Chief Business Officer
Period of report
Jun 20, 2026
Accepted (ET)
Jun 23, 2026 · 5:45 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 20, 2026 | A | 500,000 | $0.00 | A | 1,506,552 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units ("RSUs"), 40% of which will vest on June 20, 2027, and the remaining 60% of which will vest on June 20, 2028 subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Each RSU represents the right to receive one share of common stock upon vesting.